Park Avenue Securities LLC Amgen Inc Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Amgen Inc stock. As of the latest transaction made, Park Avenue Securities LLC holds 31,404 shares of AMGN stock, worth $8.27 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

31,404

Previous 35,171 10.71%

Holding current value

$8.27 Million

Previous $11 Million 7.92%

% of portfolio

0.11%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$309.38 - $337.38 $1.17 Million - $1.27 Million	-3,767 Reduced 10.71%	31,404 $10.1 Million
Q2 2024 Jul 09, 2024	BUY	$262.75 - $319.31 $925,142 - $1.12 Million	3,521 Added 11.12%	35,171 $11 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $94,911 - $114,569	353 Added 1.13%	31,650 $9 Million
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $449,776 - $507,401	1,759 Added 5.96%	31,297 $9.01 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $1.02 Million - $1.27 Million	4,660 Added 18.73%	29,538 $7.94 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $48,639 - $57,514	-227 Reduced 0.9%	24,878 $5.52 Million
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $225,338 - $274,649	998 Added 4.14%	25,105 $6.07 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $312,854 - $397,519	1,366 Added 6.01%	24,107 $0
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $412,557 - $465,289	1,838 Added 8.79%	22,741 $5.13 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $306,382 - $340,950	1,328 Added 6.78%	20,903 $5.09 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $2.73 Million - $3.02 Million	12,437 Added 174.24%	19,575 $4.73 Million
Q4 2021 Apr 08, 2022	BUY	$198.88 - $227.6 $55,885 - $63,955	281 Added 4.1%	7,138 $1.61 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $24,198 - $28,351	114 Added 1.69%	6,857 $1.46 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $88,993 - $98,732	381 Added 5.99%	6,743 $1.64 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $29,957 - $34,911	135 Added 2.17%	6,362 $1.58 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $16,877 - $20,098	-78 Reduced 1.24%	6,227 $1.43 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $56,081 - $62,367	239 Added 3.94%	6,305 $1.6 Million
Q2 2020 Jul 30, 2020	BUY	$197.81 - $242.74 $57,364 - $70,394	290 Added 5.02%	6,066 $1.43 Million
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $267,163 - $354,332	1,466 Added 34.01%	5,776 $1.17 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $235,377 - $302,540	1,244 Added 40.57%	4,310 $1.04 Million
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $13,232 - $15,855	-76 Reduced 2.42%	3,066 $593,000
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $677,302 - $793,950	-4,063 Reduced 56.39%	3,142 $579,000
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $1.3 Million - $1.47 Million	7,205 New	7,205 $1.38 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Amgen Inc Transaction History